Lv11
60 积分 2023-03-24 加入
. ABBV-969: A first-in-class dual-targeting PSMA STEAP1 drug conjugate for the treatment of metastatic castrate resistant prostate cancer
2小时前
求助中
Characterization of an anti-STEAP1 T-cell dependent bispecific antibody for the treatment of prostate cancer and associated toxicity in cynomolgus monkeys
1个月前
已完结
The anti-STEAP1/PSMA ADC, DXC008: Assessment of anti-tumor efficacy, pharmacokinetic, and toxicity properties
2个月前
已关闭
Integrated isotyping and CDR identification of mouse monoclonal antibodies using multiplex RT-PCR
6个月前
已完结
A trispecific antibody engaging T cells with tumour and myeloid cells augments antitumour immunity
7个月前
已完结
The PSMA-targeting Half-life Extended BiTE Therapy AMG 160 has Potent Antitumor Activity in Preclinical Models of Metastatic Castration-resistant Prostate Cancer
11个月前
已完结
皖公网安备34019202002308
